Related Experiment Videos
Unilateral generalized morphea in childhood.
Yayoi Nagai1, Tomoyasu Hattori, Osamu Ishikawa
1Division of Dermatology, Tone Central Hospital, Numata, Gunma, Japan.
The Journal of Dermatology
|August 20, 2002
Summary
This case study details a pediatric patient with unilateral generalized morphea, a rare autoimmune skin condition. Topical corticosteroids effectively treated the morphea, leading to softer skin and no disease progression.
Area of Science:
- Dermatology
- Pediatric Autoimmune Diseases
- Connective Tissue Diseases
Background:
- Morphea is a localized sclerosing autoimmune disease affecting the skin and subcutaneous tissue.
- Pediatric morphea can present with varied distributions and may impact quality of life.
- Understanding the immunopathogenesis and treatment responses in children is crucial.
Observation:
- A 6-year-old boy presented with unilateral generalized morphea on his lower leg, trunk, and upper arm.
- Skin biopsy revealed significant collagen bundle accumulation in the dermis and subcutaneous fat.
- Elevated levels of antinuclear antibodies, rheumatoid factor, and anti-single-stranded DNA antibodies were detected.
Findings:
- Histopathology confirmed dense collagen deposition characteristic of morphea.
- Immunological markers indicated an autoimmune process.
- The patient experienced no severe deformities or functional limitations.
Implications:
- Topical corticosteroid therapy demonstrated efficacy in softening sclerotic skin in pediatric morphea.
- Early intervention may prevent disease progression and functional impairment.
- This case highlights the importance of prompt diagnosis and management of morphea in children.